Saturday 17 October 2026
Export AEMD’s income statement to Excel — free account
Aethlon Medical, Inc.
AEMD Healthcare Medical Devices
Aethlon Medical, Inc.’s revenue for fiscal 2023 (year ended March 2023) was $574,200.00, up 95.2% from fiscal 2022. In the quarter to June 2026, EPS grew 90.5% and free cash flow fell 11.1%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
5.15
0.12
−2.28%
Follow AEMD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.32 | 5.53 | 3.47 | 4.76 | |
Current Ratio |
4.45 | 5.68 | 3.85 | 5.42 | |
Net Debt/EBITDA |
4.31 | 3.65 | 2.43 | 3.45 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.12 | 0.93 | 0.93 | 1.23 | |
Capex/Depreciation |
0.00 | (0.01) | 0.01 | (0.06) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(20.87) | (11.39) | (12.99) | (4.93) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.02) | |
Free Cash Flow per Share |
(20.87) | (11.40) | (13.00) | (4.95) | |
Cash per Share |
73.63 | 42.26 | 37.29 | 12.82 | |
Shareholders Equity per Share |
72.28 | 40.78 | 36.25 | 13.52 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
72.28 | 40.78 | 36.25 | 13.52 | |
Free Cash Flow |
(1.66) | (1.88) | (1.75) | (1.91) | |
Working Capital |
4.85 | 5.88 | 4.12 | 4.57 | |
Capital Expenditures |
— | 0.00 | 0.00 | (0.01) | |
Net Current Asset Value |
4.68 | 5.80 | 4.12 | 4.57 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.18 | — | — | — | |
Average Payables |
0.75 | 0.54 | 0.46 | 0.49 | |
Average Assets |
8.09 | 7.29 | 6.85 | 5.77 | |
Average Common Equity |
5.88 | 5.52 | 5.00 | 4.31 |
Columns are period end dates